20 articles
Engineered cerium-peptide microspheres show 76% reduction in IBD symptoms and 66% decrease in fibrosis markers in mouse studies.
Combined therapy restored gut health in patients who failed conventional treatments, offering new hope for refractory IBD cases.
Researchers identify a gut-microbe-driven pathway linking IBS-D and insulin resistance, with oleoylethanolamide as a key therapeutic molecule.
New research shows this beneficial gut microbe blocks obesity and improves metabolism through nicotinamide riboside production.
A microbial enzyme from Bifidobacterium enhances anti-TNF therapy efficacy in IBD by reshaping immune regulation via histone lactylation.
A double-blind RCT finds FMT capsules added to escitalopram reduce depression scores faster via bile acid and anti-inflammatory pathways.
Study shows fasting improves cognitive performance in obesity by modifying gut bacteria and enhancing brain immune cells.
New research reveals diagnostic challenges in identifying fatty liver disease in lean individuals using current screening tools.
A microbiota-derived short-chain fatty acid stops Candida colonization by acidifying fungal cells — a finding with major implications for immunocompromised patients.
Go beyond probiotics and fiber — explore the cutting-edge science of fecal microbiota transplantation, engineered postbiotics, and how the gut orchestrates systemic aging through immune and neural circuits.
New research reveals how specific gut bacteria can program neutrophils to become cancer-fighting allies in colorectal tumors.
Fecal microbiota transplants dramatically improved immune checkpoint inhibitor response rates in lung cancer and melanoma patients.
New research shows how a specific gut bacteria enhances anti-PD-1 therapy effectiveness in hard-to-treat colorectal cancers.
Enhanced probiotic formula reduces intestinal fibrosis by boosting beneficial bile acids that calm inflammatory responses.
A common oat fiber supercharges anti-PD-1 checkpoint therapy by expanding a key gut microbe that produces immune-activating metabolites.
New research calls for refined approaches to identify and monitor liver disease risk in non-obese patients with fatty liver.
Scientists develop gut-targeted compound that protects liver and boosts nutrient absorption after small bowel surgery, offering hope where no treatments exist.
Clinical trial tests safety of combined prebiotic-probiotic supplement in 32 healthy participants over 5 months.
University study tests whether combining probiotics with prebiotics can restore healthy gut bacteria and immune function in people over 65.
Clinical trial tests whether fecal transplants from young, active donors can restore muscle strength and cognitive function in older adults.
